Patel Rajiv M, Downs-Kelly Erinn, Weiss Sharon W, Folpe Andrew L, Tubbs Raymond R, Tuthill Ralph J, Goldblum John R, Skacel Marek
Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30355, USA.
Mod Pathol. 2005 Dec;18(12):1585-90. doi: 10.1038/modpathol.3800503.
Clear cell sarcoma of soft tissue (malignant melanoma of soft parts) is a soft tissue sarcoma with melanocytic differentiation that typically occurs in the tendons and aponeuroses of young adults. As demonstrated by cytogenetics and reverse-transcriptase polymerase chain reaction, between 70% and over 90% of clear cell sarcomas have a t(12;22) translocation, fusing the EWS and ATF1 genes on chromosomes 22q12 and 12q13, respectively. Identification of this translocation distinguishes clear cell sarcoma from histologic mimics, most importantly conventional malignant melanoma. We report our experience with a commercially available, dual-color, break-apart fluorescence in situ hybridization (FISH) probe, which allows detection of EWS (22q12) gene rearrangement in formalin-fixed, paraffin-embedded tissues. Histologically and immunophenotypically well-characterized cases of clear cell sarcoma (n = 10) and malignant melanoma (n = 32) were evaluated with a 22q12 dual-color, break-apart probe (Vysis, Downer's Grove, IL, USA), which spans the known common breakpoints in the EWS gene on chromosome 22 (introns 7-10). Signals from tumor cell nuclei were counted under a fluorescence microscope and the presence of red-green break-apart signals was recorded. Of the clear cell sarcoma cases, seven of 10 showed evidence of an EWS gene rearrangement with a mean of 81.6% positive cells per sample (range: 60-95%). All cases of malignant melanoma (n = 32) showed virtually absent break-apart signals in the EWS gene (less than 4% cells per case). FISH detects EWS gene rearrangement in a substantial proportion of clear cell sarcomas, with excellent specificity. Importantly, EWS FISH is negative in malignant melanoma, a clinically dissimilar tumor, which may closely mimic clear cell sarcoma histologically and immunohistochemically. As the studied probe can be utilized in routinely processed tissue, FISH provides an excellent alternative to reverse-transcriptase polymerase chain reaction in cases where fresh tissue is unavailable.
软组织透明细胞肉瘤(软组织恶性黑色素瘤)是一种具有黑素细胞分化的软组织肉瘤,通常发生于年轻人的肌腱和腱膜。细胞遗传学和逆转录酶聚合酶链反应显示,70%至90%以上的透明细胞肉瘤存在t(12;22)易位,分别使22号染色体q12区域的EWS基因与12号染色体q13区域的ATF1基因融合。这种易位的鉴定可将透明细胞肉瘤与组织学上的相似肿瘤区分开来,最重要的是与传统恶性黑色素瘤区分开来。我们报告了使用一种市售的双色、分离型荧光原位杂交(FISH)探针的经验,该探针可检测福尔马林固定、石蜡包埋组织中的EWS(22q12)基因重排。对组织学和免疫表型特征明确的透明细胞肉瘤病例(n = 10)和恶性黑色素瘤病例(n = 32),使用一种跨越22号染色体上EWS基因已知常见断点(内含子7 - 10)的22q12双色、分离型探针(Vysis,美国伊利诺伊州唐纳格罗夫)进行评估。在荧光显微镜下对肿瘤细胞核的信号进行计数,并记录红绿分离信号的存在情况。在透明细胞肉瘤病例中,10例中有7例显示EWS基因重排的证据,每个样本阳性细胞的平均比例为81.6%(范围:60 - 95%)。所有恶性黑色素瘤病例(n = 32)在EWS基因中几乎未显示分离信号(每个病例少于4%的细胞)。FISH在相当比例的透明细胞肉瘤中检测到EWS基因重排,特异性良好。重要的是,EWS FISH在恶性黑色素瘤中为阴性,恶性黑色素瘤是一种临床症状不同的肿瘤,在组织学和免疫组织化学上可能与透明细胞肉瘤极为相似。由于所研究的探针可用于常规处理的组织,在无法获得新鲜组织的情况下,FISH为逆转录酶聚合酶链反应提供了极佳的替代方法。